Q-omics provides the consensus-scored MIR3176 profile across patient tissues and cancer cell-line models. MIR3176 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in LGG. Among the 18 cancer types available for tumor–normal comparison, MIR3176 is differentially expressed in 13, with the highest sampling consensus in COAD. Additionally, MIR3176 RNA expression shows 18,576 significant gene co-expression associations, with the highest sampling consensus in DLBC. Together, these results highlight LGG, COAD, and DLBC as cancer lineages where MIR3176 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3176 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3176 survival associations across molecular data types. MIR3176 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3176 RNA expression–survival associations across cancer types. High MIR3176 expression shows unfavorable associations in LGG, KIRC, UVM, LUAD, THCA and UCEC. The LGG Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for MIR3176 RNA expression.
This table summarizes MIR3176 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3176. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3176 shows lower tumor expression in THCA and higher tumor expression in COAD, KICH, STAD, UCEC and HNSC. The COAD box plot shows higher MIR3176 RNA expression in tumor versus normal tissue (log2 FC = +0.998, t-test p < 0.001).
This table shows molecular features associated with MIR3176 in patient tissues and cancer cell lines. In patient samples, MIR3176 shows the broadest associations at the RNA and protein expression levels, with DLBC recurring as the lineage with the largest associated feature set.
